Stocks to Buy on Do...
Health Care: Drugs
Salix Pharmaceuticals Ltd. (SLXP: NASDAQ)
$48.80 0.37 | 0.76%
02/08/12 - 01:29 PM ET
208.18K / 943.20K
Vol / Avg. Vol:48.74 / 48.43
Open / Prev. Close:48.33 - 49.09
Today's Range:25.64 - 50.28
52 Wk Range:1.21%
Performance YTD:TheStreet Rating:
Portfolios with SLXP
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ProDiscovery Capital Management
- Contributor10 Pharma Stocks With Upside
- ProFidelity Select Pharmaceuti...
- Contributor10 Biotech Stocks Facing FD...
- UserTop Healthcare Short Squeez...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- UserBarron's Research Reports 3...
- Usercazzconsult Portfolio 1
Latest SLXP Headlines from TheStreet
- Salix Stock Hits New 52-Week High (SLXP) 01.10.12 | 09:01 am
- Analysts' Actions: EXPE, WAG, UAL, RE 12.23.11 | 09:12 am
- Salix Stock Gaps Up On Today's Open (SLXP) 12.20.11 | 09:12 am
- Salix Stock Gaps Up On Today's Open (SLXP) 11.17.11 | 09:11 am
- Salix Pharmaceuticals Ltd. Stock Upgraded (SLXP) 11.14.11 | 05:11 am
- Salix Pharmaceuticals Ltd. (SLXP): Today's Featured Drugs Winner 11.09.11 | 04:11 pm
- 8 Stocks Rising on Unusual Volume 11.09.11 | 12:11 pm
- Salix Stock Hits New 52-Week Low (SLXP) 09.22.11 | 10:09 am
- Salix Stock Hits New 52-Week Low (SLXP) 09.12.11 | 11:09 am
- Salix Stock Hits New 52-Week Low (SLXP) 08.18.11 | 03:08 pm
Press Releases for SLXP
- Salix Pharmaceuticals Announces FDA Granting Of Priority Review Designation For The Crofelemer NDA For Treatment Of Diarrhea In Patients With HIV/AIDS On Anti-Retroviral Therapy - Business Wire 02.07.12 | 07:02 am
- Salix Pharmaceuticals To Present At J.P. Morgan Healthcare Conference - Business Wire 01.04.12 | 10:01 am
- Salix Pharmaceuticals Completes Acquisition Of Oceana Therapeutics - Business Wire 12.20.11 | 02:12 pm
- Salix And Progenics Announce Positive Highly Statistically Significant Results Of Oral Methylnaltrexone For Phase 3 Trial In Chronic, Non-Cancer Pain Subjects With Opioid-Induced Constipation - Business Wire 12.20.11 | 07:12 am
- Salix Pharmaceuticals Announces NDA Submission For Crofelemer For The Treatment Of HIV-Associated Diarrhea - Business Wire 12.14.11 | 07:12 am
- Salix Pharmaceuticals To Present At Oppenheimer Healthcare Conference - Business Wire 11.29.11 | 07:11 am
- Salix Pharmaceuticals To Acquire Oceana Therapeutics - Business Wire 11.08.11 | 04:11 pm
- Salix Pharmaceuticals Reports 3Q2011 Results And Raises 2011 Guidance - Business Wire 11.08.11 | 04:11 pm
- Salix Pharmaceuticals Previews Data Slated For Presentation At 62nd Annual Meeting Of The American Association For The Study Of Liver Diseases - Business Wire 11.04.11 | 07:11 am
- Salix Pharmaceuticals To Present At Two Investment Conferences In November - Business Wire 11.03.11 | 07:11 am
Partner Headlines for SLXP
- Piper Jaffray Reinforces Bullish Thesis for Salix Pharmaceuticals - Benzinga 01.23.12 | 09:01 am
- ETF Showdown: Fun With Pharma - Benzinga 12.30.11 | 04:12 pm
- 5 Stocks Posting Big Jumps On Tuesday - Seeking Alpha 12.21.11 | 07:12 am
- Morning Market Movers - Benzinga 12.20.11 | 09:12 am
- Salix Pharmaceuticals - Aggressive Growth - Zacks 12.19.11 | 01:12 am
- Zacks Bull and Bear of the Day Highlights: Salix Pharmaceuticals, Montpelier Re Holdings, Wal-Mart, Macy's and Best Buy - Press Releases - Zacks 11.28.11 | 09:11 am
- Salix Pharmaceuticals (SLXP) - Bull of the Day - Zacks 11.28.11 | 01:11 am
- Salix Beats on Higher Revenues - Analyst Blog - Zacks 11.11.11 | 09:11 am
- Company News for November 10, 2011 - Corporate Summary - Zacks 11.10.11 | 10:11 am
- John Paulson's New Bullish Bets - Seeking Alpha 09.08.11 | 09:09 am
